Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer

NCT06138028 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Esophageal Squamous Cell Carcinoma

Interventions

DRUG: TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）

Sponsor

Qingdao Central Hospital